According to Swedish and Dutch experts, there’s often a bias problem in Artificial Intelligence (AI) programs designed to grade prostate cancer (PCa) aggressiveness. That is, those who develop algorithms that are trained on a particular set of data are also the people who evaluate their accuracy. Where’s the objectivity in that method? There’s a risk […] CONTINUE
Landmark clinical study shows MRgFUS effective for bone mets pain.
A Landmark Study on Palliation of Bone Mets PainWhen a primary cancer such as cancer of the breast, prostate or lung spreads to the bone (bone mets), treatment strategies become complex. In today’s world of oncology, better systemic chemotherapies can add months and even years to a patient’s life; in addition, local cancer control of […] KEEP READING